India · Delayed Price · Currency is INR Parnax Lab Company Description
Parnax Lab Limited engages in the manufacture and export of pharmaceutical formulations in India and internationally.
The company offers pharmaceutical products in the form of liquids, ointments, gels, creams, tablets, and capsules; cosmetic products; herbal products; and nutraceutical products.
It also provides Oral Formulations, such as cough expectorants, antacids, antihistamines, multi-vitamins, enzyme preparations, pediatric formulations, formulations for geriatrics, highly viscous products, and suspensions.
In addition, the company provides drug identification and development services; in- and out-licensing services; and contract research and manufacturing services The company was formerly known as Krishna-Deep Trade & Investments Limited and changed its name to Parnax Lab Limited in April 2012.
The company was incorporated in 1982 and is headquartered in Mumbai, India.
| Country | India |
| Founded | 1982 |
| Industry | Pharmaceutical Preparations |
| Employees | 12 |
| CEO | Mihir Shah |
Contact Details
Address: Bldg. No.8 Mumbai, 400022 India | |
| Phone | 91 22 6825 2525 |
| Website | naxparlab.com |
Stock Details
| Ticker Symbol | 506128 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Mihir Shah | Chief Executive Officer |
| Binoy Shah | Chief Financial Officer |